Search Results 411-420 of 24224 for In situ

  1. Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    EXCEPTIONS: Non-melanotic skin cancer or carcinoma-in-situ of the cervix. NOTE: If there is a history of other malignancy, the patient must not be receiving ...

  2. An Investigational Drug (TPST-1495) In Patients With Familial Adenomatous Polyposis - Mayo Clinic

    TPST-1495 may help reduce the number of polyps in the small bowel and colon in patients with FAP. ... in situ, or basal or squamous cell carcinomas of the skin) * ...

  3. Efficacy And Safety Of SANGUINATE™ For Reduction Of Delayed Graft Function In Patients Receiving A Kidney Transplant - Mayo Clinic

    Efficacy And Safety Of SANGUINATE™ For Reduction Of Delayed Graft Function In Patients Receiving A Kidney Transplant ... in situ, or early detected prostate ...

  4. General Surgery in Phoenix - Doctors - Mayo Clinic

    ... in situ, Lobular carcinoma in situ, Fibroadenoma, Male breast cancer, Breast cysts and lumps, Triple-negative breast cancer, Invasive ductal carcinoma ...

  5. Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405) - Mayo Clinic

    - in situ cervical cancer - low grade prostate adenocarcinoma (Gleason grade ≤ 6) managed with observation and stable for 6 months. - Patients should not ...

  6. Coping with pain after breast surgery - Mayo Clinic

    Dragon Boats and Breast Cancer · Ductal carcinoma in situ (DCIS) · Enlarged breasts in men (gynecomastia) · Genetic Testing for Breast Cancer · Genetic testing ...

  7. Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer - Mayo Clinic

    - HER2 positive (3+ by IHC or fluorescence in situ hybridization [FISH] amplified) breast cancer by ASCO/CAP guidelines. - Estrogen receptor (ER) and/or ...

  8. The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS) - Mayo Clinic

    (Basal or squamous cell carcinoma of the skin, carcinoma in situ of the cervix, carcinoma in situ of the breast, and incidental histologic finding of ...

  9. Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission - Mayo Clinic

    ... in First Complete Remission ... in minimal residual disease-negative mantle cell lymphoma in first complete remission. ... situ carcinoma, melanoma in situ post ...

  10. A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. ... in situ cervical cancer or other in situ ...